Amphastar Pharmaceuticals hired a private detective firm to poke around in the lives of both Janet Woodcock, the director of FDA's Center for Drug Evaluation and Research, and Moheb Nasr, who is in charge of the Office of New Drug Quality Assessment, Politico reports. The company says it wanted to determine whether the officials were favoring its competitor, Momenta. The investigative firm Kroll, Politico reports, came up empty.